Les anticorps monoclonaux anti-TNF-α dans le traitement de la polyarthrite rhumatoïde
- 31 October 2000
- journal article
- review article
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 21 (10), 854-862
- https://doi.org/10.1016/s0248-8663(00)00236-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Therapeutic actions of cyclosporine and anti-tumor necrosis factor ? in collagen-induced arthritis and the effect of combination therapyArthritis & Rheumatism, 1998
- Deactivation of vascular endothelium by monoclonal anti–tumor necrosis factor α antibody in rheumatoid arthritisArthritis & Rheumatism, 1996
- Decrease in cellularity and expression of adhesion molecules by anti–tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritisArthritis & Rheumatism, 1996
- THE THERAPEUTIC EFFECTS OF AN ENGINEERED HUMAN ANTI-TUMOUR NECROSIS FACTOR ALPHA ANTIBODY (CDP571) IN RHEUMATOID ARTHRITISRheumatology, 1995
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994
- Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritisThe Lancet, 1994
- Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritisThe Lancet, 1994
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993
- Soluble tumor necrosis factor receptors in human inflammatory synovial fluidsArthritis & Rheumatism, 1993
- Tumour necrosis factor-α in murine autoimmune 'lupus' nephritisNature, 1988